BACKGROUND Although skin diseases are often immediately visible to both patients and society, the morbidity they cause is only poorly defined. It has been suggested that quality-of-life measures may be a relevant surrogate measure of skin disease. Hidradenitis suppurativa (HS) leads to painful eruptions and malodorous discharge and is assumed to cause a significant degree of morbidity. The resu...

Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Globa...

The evaluation of quality of life (QoL) and its modification through therapeutic interventions has become a prioritary concern in recent years and a requirement on the part of regulatory agencies for the authorization of new drugs. In clinical studies of allergic disorders, particularly allergic rhinitis and urticaria, different types of generic questionnaires have been used - especially diseas...

BACKGROUND Hirsutism can have negative impacts on psychosocial aspects of women's lives and reduce their quality of life (QOL). The aim of this study was to assess the QOL of these women during laser treatment. PATIENTS AND METHODS Eighty-eight women with unwanted facial hair underwent laser therapy. Each patient completed a questionnaire consisting of a modified Dermatology Life Quality Inde...

BACKGROUND A number of disease-severity and quality-of-life (QoL) instruments have emerged in atopic dermatitis (AD) in the last decade. OBJECTIVES To identify trends in outcomes instruments used in AD clinical trials and to provide a useful summary of the dimensions and validation studies for the most commonly used measures. METHOD All randomized control trials (RCTs) from 1985 to 2010 in ...

© 2011 The Authors. doi: 10.2340/00015555-1075 Journal Compilation © 2011 Acta Dermato-Venereologica. ISSN 0001-5555 A total of 334 end-stage renal disease patients with moderate-to-severe uraemic xerosis were surveyed for quality of life assessment, using the generic Short-Form (SF-12) scale and the Dermatology Life Quality Index (DLQI). In parallel, the intensity of xerosis at four sites (the...

Psoriasis can be classified as mild, moderate, or severe. Given the great variability in the clinical forms of the disease, many different instruments are currently used to assess severity in these patients. However, all of these methods have limitations. Currently, the most used instruments are the Psoriasis Area Severity Index (PASI), body surface area (BSA), Investigator’s Global Assessment ...

Background: Quality of life (QoL) assessment is becoming crucial in clinical trials, particularly with psoriasis. Objectives: The aim of this study was to evaluate QoL by the Moroccan version of the DLQI (Dermatology Life Quality Index) among psoriatic patients compared to vitiligo. Methods: This is a prospective study of patients aged 18 or older, who consulted at the dermatology clinic for ps...